Artelon Metatarsophalangeal (MTP) Spacer

NCT01028469 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2009-12-15

No results posted yet for this study

Summary

The aim of this prospective, case series is to evaluate the surgical treatment of painful and disabling osteoarthrosis in the MTP-I joint by insertion of an Artelon MTP Spacer.

Conditions

Interventions

DEVICE

Artelon MTP Spacer

Metatarsophalangeal hemi-implant

Sponsors & Collaborators

  • Artimplant AB

    lead INDUSTRY

Principal Investigators

  • Martin Alund, M.D. · Sahlgrenska University Hospital, Mölndal, Sweden

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01028469 on ClinicalTrials.gov